Marianne Chapleau provides a review on the application of amyloid PET in neurodegenerative diseases. Comprehensive overview of clinical, pathology and imaging correlates; going through comparisons between PET and fluid biomarkers; and ending on thoughts about application of amyloid PET on clinical trials.
